{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:33:39Z","timestamp":1760146419057},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2000,12,1]],"date-time":"2000-12-01T00:00:00Z","timestamp":975628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2000,12,1]],"date-time":"2000-12-01T00:00:00Z","timestamp":975628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2000,12,1]]},"DOI":"10.1038\/sj.leu.2401934","type":"journal-article","created":{"date-parts":[[2002,9,4]],"date-time":"2002-09-04T18:28:09Z","timestamp":1031164089000},"page":"2076-2084","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Disease- and treatment-related elevation of the neurodegenerative marker tau in children with hematological malignancies"],"prefix":"10.1038","volume":"14","author":[{"given":"SW","family":"Van Gool","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Van Kerschaver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Brock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Pottel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Hulstaert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Vanmechelen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Uyttebroeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Van De Voorde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Vanderstichele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2000,12,20]]},"reference":[{"key":"BF2401934_CR1","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1002\/1097-0142(19950415)75:8<2186::AID-CNCR2820750825>3.0.CO;2-F","volume":"75","author":"JG Gurney","year":"1995","unstructured":"Gurney JG, Severson RK, Davis S, Robison LL . Incidence of cancer in children in the United States. Sex-, race-, and 1-year age-specific rates by histologic type Cancer 1995 75: 2186\u20132195","journal-title":"Cancer"},{"key":"BF2401934_CR2","first-page":"87","volume":"26","author":"G Henze","year":"1981","unstructured":"Henze G, Langermann HJ, Ritter J, Schellong G, Riehm H . Treatment strategy for different risk group in childhood acutelymphoblastic leukemia: a report from the BFM Study Group H\u00e4matol-Bluttransfus 1981 26: 87\u201393","journal-title":"H\u00e4matol-Bluttransfus"},{"key":"BF2401934_CR3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/S0959-8049(96)00508-4","volume":"33","author":"G Henze","year":"1997","unstructured":"Henze G . Childhood acute lymphoblastic leukaemia Eur J Cancer 1997 33: 8\u20139","journal-title":"Eur J Cancer"},{"key":"BF2401934_CR4","first-page":"131","volume":"3","author":"M Goedert","year":"1997","unstructured":"Goedert M . The neurofibrillary pathology of Alzheimer's disease Prog Clin Neurosci 1997 3: 131\u2013141","journal-title":"Prog Clin Neurosci"},{"key":"BF2401934_CR5","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1212\/WNL.52.8.1555","volume":"52","author":"F Hulstaert","year":"1999","unstructured":"Hulstaert F, Blennow K, Ivanoiu A, Schoonderwaldt HC, Riemenschneider M, De Deyn PP, Bancher C, Cras P, Wiltfang J, Mehta PD, Iqbal K, Pottel H, Vanmechelen E, Vanderstichele H . Improved discrimination of AD patients using \u03b2-amyloid(1\u201342) and tau levels in CSF Neurology 1999 52: 1555\u20131562","journal-title":"Neurology"},{"key":"BF2401934_CR6","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/S0304-3940(97)00215-2","volume":"225","author":"M Otto","year":"1997","unstructured":"Otto M, Wiltfang J, Tumani H, Zerr I, Lantsch M, Kornhuber J, Weber T, Kretzschmar HA, Poser S . Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt\u2013Jakob disease Neurosci Lett 1997 225: 210\u2013212","journal-title":"Neurosci Lett"},{"key":"BF2401934_CR7","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1136\/jnnp.64.3.298","volume":"64","author":"N Andreasen","year":"1998","unstructured":"Andreasen N, Vanmechelen E, van de Voorde A, Davidson P, Hesse C, Tarvonen S, Raiha I, Sourander L, Winblad B, Blennow K . Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study J Neurol Neurosurg Psych 1998 64: 298\u2013305","journal-title":"J Neurol Neurosurg Psych"},{"key":"BF2401934_CR8","first-page":"189","volume-title":"Research Advances in Alzheimer's Disease and Related Disorders","author":"A Van De Voorde","year":"1995","unstructured":"Van De Voorde A, Vanmechelen E, Vandermeeren M, Dessaint F, Beeckman W, Cras P . Detection of tau in cerebrospinal fluid. In: Iqbal K, Mortimer JA, Winblad B, Wisniewski HM (eds) Research Advances in Alzheimer's Disease and Related Disorders John Wiley: Chichester 1995 189\u2013195"},{"key":"BF2401934_CR9","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/BF00313180","volume":"223","author":"H Lofberg","year":"1980","unstructured":"Lofberg H, Grubb AO, Sveger T, Olsson JE . The cerebrospinal fluid and plasma concentrations of gamma-trace and beta2-microglobulin at various ages and in neurological disorders J Neurol 1980 223: 159\u2013170","journal-title":"J Neurol"},{"key":"BF2401934_CR10","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/clinchem\/38.6.813","volume":"38","author":"BG van Engelen","year":"1992","unstructured":"van Engelen BG, Lamers KJ, Gabreels FJ, Wevers RA, van Geel WJ, Borm GF . Age-related changes of neuron-specific enolase, S-100 protein, and myelin basic protein concentrations in cerebrospinal fluid Clin Chem 1992 38: 813\u2013816","journal-title":"Clin Chem"},{"key":"BF2401934_CR11","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1080\/00365519850186562","volume":"58","author":"O Nygaard","year":"1998","unstructured":"Nygaard O, Langbakk B, Romner B . Neuron-specific enolase concentrations in serum and cerebrospinal fluid in patients with no previous history of neurological disorder Scand J Clin Lab Invest 1998 58: 183\u2013186","journal-title":"Scand J Clin Lab Invest"},{"key":"BF2401934_CR12","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/clinchem\/43.3.541","volume":"43","author":"O Nygaard","year":"1997","unstructured":"Nygaard O, Langbakk B, Romner B . Age- and sex-related changes of S-100 protein concentrations in cerebrospinal fluid and serum in patients with no previous history of neurological disorder Clin Chem 1997 43: 541\u2013543","journal-title":"Clin Chem"},{"key":"BF2401934_CR13","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1136\/adc.58.12.953","volume":"58","author":"L Jannoun","year":"1983","unstructured":"Jannoun L . Are cognitive and educational development affected by age at which prophylactic therapy is given in acute lymphoblastic leukaemia? Arch Dis Child 1983 58: 953\u2013958","journal-title":"Arch Dis Child"},{"key":"BF2401934_CR14","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/S0031-3955(16)36510-5","volume":"35","author":"WA Bleyer","year":"1988","unstructured":"Bleyer WA . Central nervous system leukemia Pediatr Clin North Am 1988 35: 789\u2013814","journal-title":"Pediatr Clin North Am"},{"key":"BF2401934_CR15","first-page":"131","volume":"12","author":"WA Bleyer","year":"1985","unstructured":"Bleyer WA, Poplack DG . Prophylaxis and treatment of leukemia in the central nervous system and other sanctuaries Semin Oncol 1985 12: 131\u2013148","journal-title":"Semin Oncol"},{"key":"BF2401934_CR16","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1097\/00043426-198921000-00016","volume":"11","author":"SJ Lauer","year":"1989","unstructured":"Lauer SJ, Kirchner PA, Camitta BM . Identification of leukemia cells in the cerebrospinal fluid from children with acute lymphoblastic leukemia: advances and dilemmas Am J Pediatr Hematol Oncol 1989 11: 64\u201373","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"BF2401934_CR17","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/00043426-198608010-00006","volume":"8","author":"S Mclntosh","year":"1986","unstructured":"Mclntosh S, Ritchey AK . Diagnostic problems in cerebrospinal fluid of children with lymphoid malignancies Am J Pediatr Hematol Oncol 1986 8: 28\u201331","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"BF2401934_CR18","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1200\/JCO.1996.14.1.18","volume":"14","author":"J Smith","year":"1996","unstructured":"Smith J, Arthur D, Camitta B, Carroll AJ, Crist W, Gaynon P, Gelber R, Heerema N, Korn EL, Link M, Murphy S, Pui CH, Pullen J, Reamon G, Sallan SE, Sather H, Shuster J, Simon R, Trigg M, Tubergen D, Uckun F, Ungerleider R . Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia J Clin Oncol 1996 14: 18\u201324","journal-title":"J Clin Oncol"},{"key":"BF2401934_CR19","first-page":"203","volume":"101","author":"V Azzarelli","year":"1977","unstructured":"Azzarelli V, Roessmann U . Pathogenesis of central nervous system infiltration in acute leukemia Arch Pathol Lab Med 1977 101: 203\u2013205","journal-title":"Arch Pathol Lab Med"},{"key":"BF2401934_CR20","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1007\/BF00688182","volume":"78","author":"TA Simpson","year":"1989","unstructured":"Simpson TA, Anderson ML, Garcia JH, Barton JC . Myeloblastoma of the brain Acta Neuropathol Berl 1989 78: 444\u2013447","journal-title":"Acta Neuropathol Berl"},{"key":"BF2401934_CR21","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1176\/ajp.141.3.369","volume":"141","author":"NR Varney","year":"1984","unstructured":"Varney NR, Alexander B, Mclndoe JH . Reversible steroid dementia in patients without steroid psychosis Am J Psychiatry 1984 141: 369\u2013372","journal-title":"Am J Psychiatry"},{"key":"BF2401934_CR22","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1001\/archinte.1981.00340020077021","volume":"141","author":"MN Starkman","year":"1981","unstructured":"Starkman MN, Schteingart DE . Neuropsychiatric manifestations of patients with Cushing's syndrome. Relationship to cortisol and adrenocorticotropic hormone levels Arch Intern Med 1981 141: 215\u2013219","journal-title":"Arch Intern Med"},{"key":"BF2401934_CR23","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/0006-3223(92)90079-F","volume":"32","author":"MN Starkman","year":"1992","unstructured":"Starkman MN, Gebarski SS, Berent S, Schteingart DE . Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing's syndrome Biol Psychiatry 1992 32: 756\u2013765","journal-title":"Biol Psychiatry"},{"key":"BF2401934_CR24","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1159\/000125357","volume":"51","author":"RM Sapolsky","year":"1990","unstructured":"Sapolsky RM, Armanini MP, Packan DR, Sutton SW, Plotsky PM . Glucocorticoid feedback inhibition of adrenocorticotropic hormone secretagogue release. Relationship to corticosteroid receptor occupancy in various limbic sites Neuroendocrinology 1990 51: 328\u2013336","journal-title":"Neuroendocrinology"},{"key":"BF2401934_CR25","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1159\/000125539","volume":"52","author":"HC Horner","year":"1990","unstructured":"Horner HC, Packan DR, Sapolsky RM . Glucocorticoids inhibit glucose transport in cultured hippocampal neurons and glia Neuroendocrinology 1990 52: 57\u201364","journal-title":"Neuroendocrinology"},{"key":"BF2401934_CR26","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/hipo.450020410","volume":"2","author":"Y Watanabe","year":"1992","unstructured":"Watanabe Y, Gould E, Cameron HA, Daniels DC, McEwen BS . Phenytoin prevents stress- and corticosterone-induced atrophy of CA3 pyramidal neurons Hippocampus 1992 2: 431\u2013435","journal-title":"Hippocampus"},{"key":"BF2401934_CR27","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/hipo.450030210","volume":"3","author":"C Pavlides","year":"1993","unstructured":"Pavlides C, Watanabe Y, McEwen BS . Effects of glucocorticoids on hippocampal long-term potentiation Hippocampus 1993 3: 183\u2013192","journal-title":"Hippocampus"},{"key":"BF2401934_CR28","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/S0733-8619(18)30259-7","volume":"9","author":"DR Macdonald","year":"1991","unstructured":"Macdonald DR . Neurologic complications of chemotherapy Neurol Clin 1991 9: 955\u2013967","journal-title":"Neurol Clin"},{"key":"BF2401934_CR29","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1200\/JCO.1991.9.1.145","volume":"9","author":"J Ochs","year":"1991","unstructured":"Ochs J, Mulhern R, Fairclough D, Parvey L, Whitaker J, Chien L, Mauer A, Simone J . Comparison of neuropsychologic functioning and clinical indicators of neurotoxicity in long-term survivors of childhood leukemia given cranial radiation or parenteral methotrexate: a prospective study J Clin Oncol 1991 9: 145\u2013151","journal-title":"J Clin Oncol"},{"key":"BF2401934_CR30","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1203\/00006450-199402000-00009","volume":"35","author":"PJ Mullenix","year":"1994","unstructured":"Mullenix PJ, Kernan WJ, Schunior A, Howes A, Waber DP, Sallan SE, Tarbell NJ . Interactions of steroid, methotrexate, and radiation determine neurotoxicity in an animal model to study therapy for childhood leukemia Pediatr Res 1994 35: 171\u2013178","journal-title":"Pediatr Res"},{"key":"BF2401934_CR31","first-page":"215","volume-title":"Principles and Practice of Pediatric Oncology","author":"FM Balis","year":"1997","unstructured":"Balis FM, Holcenberg JS, Poplack DG . General principles of chemotherapy. In: Pizzo PA, Poplack DG (eds) Principles and Practice of Pediatric Oncology Lippincott-Raven: Philadelphia 1997 215\u2013272"},{"key":"BF2401934_CR32","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1200\/JCO.1986.4.4.571","volume":"4","author":"S Nand","year":"1986","unstructured":"Nand S, Messmore HL, Patel R, Fisher SG, Fisher RI . Neurotoxicity associated with systemic high-dose cytosine arabinoside J Clin Oncol 1986 4: 571\u2013575","journal-title":"J Clin Oncol"},{"key":"BF2401934_CR33","first-page":"299","volume":"26","author":"B Zdziarska","year":"1995","unstructured":"Zdziarska B, Nowacki P, Millo B . Dysfunction of the blood\u2013brain barrier in patients with acute leukemias or lymphomas of high grade malignancy Acta Haematol Pol 1995 26: 299\u2013304","journal-title":"Acta Haematol Pol"},{"key":"BF2401934_CR34","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/BF00121495","volume":"1","author":"M Suzuki","year":"1983","unstructured":"Suzuki M, Abe I, Sato H . Changes in drug delivery (by blood\u2013brain barrier dysfunction) on arachnoid leukemia: implication for CNS leukemic dissemination Clin Exp Metast 1983 1: 163\u2013171","journal-title":"Clin Exp Metast"},{"key":"BF2401934_CR35","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S0022-3476(05)80333-6","volume":"121","author":"RT Brown","year":"1992","unstructured":"Brown RT, Madan-Suvain A, Pais R, Lambert RG, Sexson S, Ragab A . Chemotherapy for ALL: cognitive and academic sequelae J Pediatr 1992 121: 885\u2013889","journal-title":"J Pediatr"},{"key":"BF2401934_CR36","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1212\/WNL.50.4.1122","volume":"50","author":"M Tulberg","year":"1998","unstructured":"Tulberg M, Rosengren L, Blomsterwall E, Karlsson JE, Wikkels C . CSF neurofilament and glial fibrillary acidic protein in normal pressure hydrocephalus Neurology 1998 50: 1122\u20131127","journal-title":"Neurology"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2401934.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2401934","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2401934.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T21:39:47Z","timestamp":1648762787000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2401934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,12,1]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2000,12,1]]}},"alternative-id":["BF2401934"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2401934","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,12,1]]},"assertion":[{"value":"8 March 2000","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2000","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2000","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}